Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
---|---|---|---|---|---|---|
2012 | Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia | Kantarjian H.M.; Thomas X.G.; Dmoszynska A.; Wierzbowska A.; Mazur G.; Mayer J.; Gau J.-P.; WEN-CHIEN CHOU ; Buckstein R.; Cermak J.; Kuo C.-Y.; Oriol A.; Ravandi F.; Faderl S.; Delaunay J.; Lys?k D.; Minden M.; Arthur C. | Journal of Clinical Oncology | 944 | 857 |